Share >  
Share
Share on Tumblr

Kewal Handa

News »

   latest by relevance
Pfizer plans to launch 15 new products in FY13
May 22, 2012 at 14:33 | Source: CNBC-TV18
Pharma major Pfizer registered a net profit of Rs 48.10 crore in the fourth quarter of FY12 in comparison to Rs 63.14 crore in the corresponding quarter last fiscal.
Pfizer's India MD Kewal Handa to retire in August
Apr 05, 2012 at 10:45 | Source: PTI
Under Handa''s leadership Pfizer India entered the branded generics market and grew in strength by mergers with Parke-Davis and Pharmacia and integration with Wyeth India, the company said.
GoM vs pharma industry: Battling for market driven pricing
Apr 03, 2012 at 22:17 | Source: CNBC-TV18
The pharma industry is on the edge of its seat with all eyes on the April 4 Group of Ministers (GoM) meeting which will decide on a final pricing policy for essential drugs, reports CNBC-TV18's Archana Shukla.
Pharma sector moots market-based pricing: Pfizer
Apr 02, 2012 at 16:36 | Source: CNBC-TV18
In an interview to CNBC-TV18, Kewal Handa, managing director of Pfizer and Vikas Dandekar, India Bureau Chief of PharmAsia News.Com discuss the issue of drug pricing.
Union Budget 2012: Pharma pins hopes on FM
Mar 12, 2012 at 18:26 | Source: CNBC-TV18
While dealing with fiscal challenges is likely to be the FM's core focus this Budget, the pharma industry, on its part, hopes that Pranab Mukherjee will also look into some of their long standing demands. CNBC-TV18s Swathi Narayanan and Archana Shukla report on the pharma and healthcare sectors' wishlist for Budget 2012.
Govt needs to relook at draft pharma pricing policy: Pfizer
Nov 02, 2011 at 13:15 | Source: CNBC-TV18
Speaking to CNBC-TV18, Kewal Handa, managing director of Pfizer said, the draft NPPP has a few positives but the government needs to re-look at it altogether.

Videos »
Pfizer plans to launch 15 new products in FY13
Pharma sector moots market-based pricing: Pfizer
GoM vs pharma industry: Battling for market driven pricing
Union Budget 2012: Pharma pins hopes on FM
Govt needs to relook at draft pharma pricing policy: Pfizer
more »

Photos »

  /  
Interact & exchange stock tips & market info »

Guest

Bannariamman  

Are you talking about Kewal Handa? is he your fund manag...

5.11 PM Apr 2nd

arcadiastoc
ks82

Platinum Member

505 Followers

Pfizer  

is highest among all foreign drug multinationals that sell medicines ...

10.00 AM Jan 5th

arcadiastoc
ks82

Platinum Member

505 Followers

Pfizer  

. "The industry is largely supportive of the NLEM List. But what we a...

8.06 PM Jan 4th

Related News »
Pfizer plans to launch 15 new products in FY13
In an interview with CNBC-TV18, Kewal Handa, MD, Pfizer said that the company has grown 14% in FY12 on a like-to-like basis, while Wyeth and Pfizer collectively grew 16% during the last fiscal. The growth has been primarily driven by central ...
May 22, 2012 at 09:26 | Source: MoneyControl.com

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window